EN
HI
Astrazeneca Pharma India Chart
Astrazeneca Pharma India Share Key Metrics
Volume
12424.00
Market Cap
20127.50 CR
LTQ@LTP
1@8312.50
ATP
8258.81
Var Margin
16.17 %
Circuit Range
6441-9661
Delivery %
55.23 %
Value
10.26 CR
ASM/GSM
No
Market Lot
1
Summary
At 10 Apr, 2026 | 11:55, Astrazeneca Pharma India share price stands at ₹8312.5, showing a 261.50% 3.25 for the day. The stock’s intraday movement has stayed between ₹8126.50 and ₹8412.50, while on a 52-week basis it has fluctuated from ₹7551.50 to ₹10691.00.
In terms of trading activity, Astrazeneca Pharma India has recorded a volume of 12424 shares, with a market capitalisation of ₹25000000. The stock’s Average Traded Price (ATP) stands at ₹825881, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,831250. The stock operates within a circuit range of ₹6441-9661, with a Value of ₹10.26 CR. The Delivery Percentage for the day is 55.23%. Additionally, Astrazeneca Pharma India currently falls under the No framework, and trades with a market lot size of 1.
Astrazeneca Pharma India Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
62.26
Sector P/B
3.36
Sec. Div. Yield
0.58
Astrazeneca Pharma India Resistance and Support
Pivot 7990
Resistance
First Resistance
8131
Second Resistance
8211
Third Resistance
8352
Support
First Support
7910
Second Support
7769
Third Support
7689
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Limited
AstraZeneca Pharma India appointed Dr. Shashank Srinivasan as Medical Director - Oncology Business Unit and Mr. Venkat Natarajan as Director - Market Access Business Unit. These key management personnel appointments are effective from April 1, 2026, strengthening the leadership team in critical areas.
Mar 31 2026 19:03:00
AstraZeneca Pharma India Limited
AstraZeneca Pharma India's postal ballot results confirm shareholder approval of material related party transactions with AstraZeneca UK Limited and AstraZeneca AB, Sweden. The resolutions passed with a significant majority of votes from non-related members, ensuring the company can proceed with these essential business dealings.
Mar 31 2026 16:03:00
Read More
About Astrazeneca Pharma India
NSE : 5610
BSE : 506820
ISIN : INE203A01020
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Ms. Shilpa Divekar Nirula | Chairperson & Independent Director |
| Mr. Praveen Rao Akkinepally | Managing Director |
Astrazeneca Pharma India Similar Stocks
Wockhardt Ltd.
1361.60
-8.10 (0.59%)
Sai Life Sciences Ltd.
996.80
18.70 (1.91%)
Natco Pharma Ltd.
1113.15
-10.55 (0.94%)
Acutaas Chemicals Ltd.
2352.30
30.20 (1.30%)
Piramal Pharma Ltd.
145.50
2.55 (1.78%)
Eris Lifesciences Ltd.
1369.60
5.50 (0.40%)
Neuland Laboratories Ltd.
14880.00
157.00 (1.07%)
Granules India Ltd.
641.20
5.70 (0.90%)
Onesource Specialty Pharma Ltd.
1390.00
14.30 (1.04%)
Poly Medicure Ltd.
1459.20
20.40 (1.42%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 8312.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 20127.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 10691.00 & 7551.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
